ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Sai Parenterals' subsidiary, Noumed Pharmaceuticals, renewed a 3-year OTC Medicines Supply Agreement with an Australian pharmacy chain, valued at approximately ₹204 Crore.
Sai Parenterals signed a ₹1,300 Crore OTC medicine supply agreement with Noumed Pharmaceuticals. The contract lasts 7.5 years with extension options.
Sai Parenterals secured a ₹104.50 Crore exclusive anti-TB product supply contract from Philippines-based PILL CORP. The ten-year agreement provides significant long-term revenue visibility and international market expansion.